- Home
- A-Z Publications
- Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents)
- Previous Issues
- Volume 12, Issue 4, 2012
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents) - Volume 12, Issue 4, 2012
Volume 12, Issue 4, 2012
-
-
Editorial [Hot Topic: Lipids in Cancer Cell Biology and Therapy Guest Editor: Jose C. Fernandez-Checa)]
More LessCancer-related morbidity is one of the leading causes of deaths in the world. Due to the social and health impact of cancer, research on cellular and molecular pathways leading to oncogenesis and carcinogenesis is one of the most active areas of biomedical investigation. Moreover, the uncovering of pathways that foster cancer growth and cell death resistance may also result in the development of more efficient therap Read More
-
-
-
Sphingolipid Modulation: A Strategy for Cancer Therapy
Authors: Antonio Delgado, Gemma Fabrias, Carmen Bedia, Josefina Casas and Jose Luis AbadSphingolipids are membrane lipids that play important roles in the regulation of cell functions and homeostasis. Alterations in their metabolism have been associated with several pathologies. For this reason, therapeutic strategies based on the design of small molecules to restore sphingolipid levels to their physiological condition have rapidly emerged. In addition, some of these new chemical entities, even if they f Read More
-
-
-
Statins and Protein Prenylation in Cancer Cell Biology and Therapy
Authors: Carmen Garcia-Ruiz, Albert Morales and Jose C. Fernandez-ChecaThe use of statins has scaled up to become one of the most prescribed medicines in the world and have been very useful in the manegement of cardiovascular diseases and related mortality. The disclosure of their chemical structure similar to that of hydroxy methyl glutaryl-CoA (HMG-CoA) revealed their ability to compete with and inhibit the rate-limiting enzyme HMG-CoA reductase that catalyzes the synthesis of mevalonat Read More
-
-
-
Alteration of Ceramide 1-O-Functionalization as a Promising Approach for Cancer Therapy
Authors: Stephanie Ballereau, Thierry Levade, Yves Genisson and Nathalie Andrieu-AbadieSphingolipids, which are complex lipidic components of the cell membranes, lie in a key position to modulate the pathways of trans-membrane signaling and allow the cell to adapt to environmental stresses. In malignancies, reduced production of some sphingolipid species able to induce apoptosis such as ceramide and conversely, increased levels of some other metabolites involved in tumor progression and drug resistan Read More
-
-
-
Cholesterol, Cardiolipin, and Mitochondria Permeabilisation
More LessApoptosis is a form of programmed cell death required for the development and for the proper functioning of multicellular organisms. It is defined by a combination of morphological and biochemical modifications that result from the activation of a family of proteases called caspases. Several pathways can lead to caspase activation and they often involve the release of apoptogenic factors normally sequestered in the mitocho Read More
-
-
-
Ceramide and Apoptosis: Exploring the Enigmatic Connections between Sphingolipid Metabolism and Programmed Cell Death
Authors: Thomas D. Mullen and Lina M. ObeidProgrammed cell death, or apoptosis, is a complex process whereby eukaryotic cells react to physiologic or pathophysiologic stimuli by undergoing genetically programmed suicide. Programmed cell death involves many well-characterized signaling pathways including permeabilization of the mitochondrial outer membrane and activation of caspases. Other pathways, such as pro-apoptotic lipid signaling, are less understood d Read More
-
-
-
Hepatocarcinogenesis and Ceramide/Cholesterol Metabolism
Sphingolipids (SLs) and cholesterol are critical structural components of membrane bilayers. Although recent evidence has revealed an emerging role of both lipids in signaling pathways, their contribution to cancer development and treatment has been largely overlooked. Sphingolipids comprise a family of bioactive lipids with divergent roles in numerous cellular processes. In particular, ceramide is the prototype of SLs Read More
-
-
-
Ganglioside GD3 as a Raft Component in Cell Death Regulation
Authors: Maurizio Sorice, Tina Garofalo, Roberta Misasi, Valeria Manganelli, Rosa Vona and Walter MalorniSubcellular organelles such as mitochondria, endoplasmic reticulum and the Golgi complex are involved in the progression of cell death program. Recent evidence unveils that Fas ligand-mediated apoptosis induces scrambling of mitochondrial and secretory organelles via a global alteration of membrane traffic that is modulated by apical caspases. On the basis of the biochemical nature of lipid rafts, composed by sphingolipids, Read More
-
-
-
Growth Inhibition of Human Non-Small Lung Cancer Cells H460 By Green Tea and Ginger Polyphenols
Authors: Mohamed Hessien, Saad El-Gendy, Thoria Donia and Morsy Abou SikkenaNon small cell lung cancer is known to resist apoptotic stimuli of various antitumor agents and become progressively incurable. The present study was undertaken to evaluate the in vitro antineoplastic effect of polyphenols extracted from both green tea (GTPs) and ginger (GPs) on non-small cell lung cancer cells (NSCLC-NCI-H460). Methods: The direct antitumor effect of GTPs and GPs on H460 cells was assessed by investigati Read More
-
-
-
Recent Developments of Small Molecule EGFR Inhibitors Based on the Quinazoline Core Scaffolds
Authors: Yu-Jing Yu-Jing, Cheng-Mei Zhang and Zhao-Peng LiuProgress in identifying and understanding the molecular and cellular causes of cancer has led to the discovery of anomalies that characterize cancer cells and that represent targets for the development of cancer therapeutics. One such target is the epidermal growth factor receptor (EGFR), a transmembrane protein that is frequently dysregulated in cancer cells and associated with the development, progression and Read More
-
-
-
Downregulation of Hypoxia-related Responses by Novel Antitumor Histone Deacetylase Inhibitors in MDAMB231 Breast Cancer Cells
Authors: Antonella Naldini, Irene Filippi, Elena Cini, Manuela Rodriquez, Fabio Carraro and Maurizio TaddeiThe tumor microenvironment is characterized by a poor circulation which results in the selection of neoplastic cells that can grow or survive under hypoxic conditions. The relationship between hypoxia and histone deacetylase (HDAC) inhibitors has been previously established. In this work we evaluated the effects of novel HDAC inhibitors (the natural peptide FR235222 and three tetrapeptide analogs) in the human breast canc Read More
-
Volumes & issues
-
Volume 25 (2025)
-
Volume 24 (2024)
-
Volume 23 (2023)
-
Volume 22 (2022)
-
Volume 21 (2021)
-
Volume 20 (2020)
-
Volume 19 (2019)
-
Volume 18 (2018)
-
Volume 17 (2017)
-
Volume 16 (2016)
-
Volume 15 (2015)
-
Volume 14 (2014)
-
Volume 13 (2013)
-
Volume 12 (2012)
-
Volume 11 (2011)
-
Volume 10 (2010)
-
Volume 9 (2009)
-
Volume 8 (2008)
-
Volume 7 (2007)
-
Volume 6 (2006)
Most Read This Month
Article
content/journals/acamc
Journal
10
5
false
en
